689 related articles for article (PubMed ID: 29412048)
21. Impaired L-arginine uptake but not arginase contributes to endothelial dysfunction in rats with chronic kidney disease.
Martens CR; Kuczmarski JM; Lennon-Edwards S; Edwards DG
J Cardiovasc Pharmacol; 2014 Jan; 63(1):40-8. PubMed ID: 24084210
[TBL] [Abstract][Full Text] [Related]
22. Arginase activity in endothelial cells: inhibition by NG-hydroxy-L-arginine during high-output NO production.
Buga GM; Singh R; Pervin S; Rogers NE; Schmitz DA; Jenkinson CP; Cederbaum SD; Ignarro LJ
Am J Physiol; 1996 Nov; 271(5 Pt 2):H1988-98. PubMed ID: 8945918
[TBL] [Abstract][Full Text] [Related]
23. Arginase and vascular aging.
Santhanam L; Christianson DW; Nyhan D; Berkowitz DE
J Appl Physiol (1985); 2008 Nov; 105(5):1632-42. PubMed ID: 18719233
[TBL] [Abstract][Full Text] [Related]
24. Gliadin activates arginase pathway in RAW264.7 cells and in human monocytes.
Barilli A; Rotoli BM; Visigalli R; Dall'Asta V
Biochim Biophys Acta; 2014 Sep; 1842(9):1364-71. PubMed ID: 24793417
[TBL] [Abstract][Full Text] [Related]
25. Arginase upregulation and eNOS uncoupling contribute to impaired endothelium-dependent vasodilation in a rat model of intrauterine growth restriction.
Grandvuillemin I; Buffat C; Boubred F; Lamy E; Fromonot J; Charpiot P; Simoncini S; Sabatier F; Dignat-George F; Peyter AC; Simeoni U; Yzydorczyk C
Am J Physiol Regul Integr Comp Physiol; 2018 Sep; 315(3):R509-R520. PubMed ID: 29741931
[TBL] [Abstract][Full Text] [Related]
26. Arginase inhibition by rhaponticin increases L-arginine concentration that contributes to Ca
Koo BH; Lee J; Jin Y; Lim HK; Ryoo S
BMB Rep; 2021 Oct; 54(10):516-521. PubMed ID: 34078530
[TBL] [Abstract][Full Text] [Related]
27. Arginine metabolism in experimental glomerulonephritis: interaction between nitric oxide synthase and arginase.
Cook HT; Jansen A; Lewis S; Largen P; O'Donnell M; Reaveley D; Cattell V
Am J Physiol; 1994 Oct; 267(4 Pt 2):F646-53. PubMed ID: 7524362
[TBL] [Abstract][Full Text] [Related]
28. Arginine catabolism in the cyanobacterium Synechocystis sp. Strain PCC 6803 involves the urea cycle and arginase pathway.
Quintero MJ; Muro-Pastor AM; Herrero A; Flores E
J Bacteriol; 2000 Feb; 182(4):1008-15. PubMed ID: 10648527
[TBL] [Abstract][Full Text] [Related]
29. L-arginine metabolism in immune-mediated glomerulonephritis in the rat.
Ketteler M; Ikegaya N; Brees DK; Border WA; Noble NA
Am J Kidney Dis; 1996 Dec; 28(6):878-87. PubMed ID: 8957040
[TBL] [Abstract][Full Text] [Related]
30. [New insights into arginase. Part II. Role in physiology and pathology].
Mielczarek-Puta M; Chrzanowska A; Graboń W; Barańczyk-Kuźma A
Postepy Hig Med Dosw (Online); 2008 May; 62():214-21. PubMed ID: 18480737
[TBL] [Abstract][Full Text] [Related]
31. Arginine and asthma.
Morris CR
Nestle Nutr Inst Workshop Ser; 2013; 77():1-15. PubMed ID: 24107492
[TBL] [Abstract][Full Text] [Related]
32. The Mechanisms of L-Arginine Metabolism Disorder in Endothelial Cells.
Mammedova JT; Sokolov AV; Freidlin IS; Starikova EA
Biochemistry (Mosc); 2021 Feb; 86(2):146-155. PubMed ID: 33832413
[TBL] [Abstract][Full Text] [Related]
33. Amino acid metabolism reflecting arginase activity is increased in patients with type 2 diabetes and associated with endothelial dysfunction.
Kövamees O; Shemyakin A; Pernow J
Diab Vasc Dis Res; 2016 Sep; 13(5):354-60. PubMed ID: 27190086
[TBL] [Abstract][Full Text] [Related]
34. Altered Expression of Urea Cycle Enzymes in Amyloid-β Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.
Jęśko H; Lukiw WJ; Wilkaniec A; Cieślik M; Gąssowska-Dobrowolska M; Murawska E; Hilgier W; Adamczyk A
J Alzheimers Dis; 2018; 62(1):279-291. PubMed ID: 29439324
[TBL] [Abstract][Full Text] [Related]
35. Arginase release by primary hepatocytes and liver slices results in rapid conversion of arginine to urea in cell culture media.
Peters SJ; Haagsman HP; van Norren K
Toxicol In Vitro; 2008 Jun; 22(4):1094-8. PubMed ID: 18348903
[TBL] [Abstract][Full Text] [Related]
36. Altered L-arginine metabolism results in increased nitric oxide release from uraemic endothelial cells.
Thuraisingham RC; Roberts NB; Wilkes M; New DI; Mendes-Ribeiro AC; Dodd SM; Yaqoob MM
Clin Sci (Lond); 2002 Jul; 103(1):31-41. PubMed ID: 12095401
[TBL] [Abstract][Full Text] [Related]
37. Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells.
Zharikov S; Krotova K; Hu H; Baylis C; Johnson RJ; Block ER; Patel J
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1183-90. PubMed ID: 18784379
[TBL] [Abstract][Full Text] [Related]
38. Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells.
Chicoine LG; Paffett ML; Young TL; Nelin LD
Am J Physiol Lung Cell Mol Physiol; 2004 Jul; 287(1):L60-8. PubMed ID: 14977627
[TBL] [Abstract][Full Text] [Related]
39. Arginase as a Critical Prooxidant Mediator in the Binomial Endothelial Dysfunction-Atherosclerosis.
Rabelo LA; Ferreira FO; Nunes-Souza V; da Fonseca LJ; Goulart MO
Oxid Med Cell Longev; 2015; 2015():924860. PubMed ID: 26064427
[TBL] [Abstract][Full Text] [Related]
40. Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis.
Balaña-Fouce R; Calvo-Álvarez E; Álvarez-Velilla R; Prada CF; Pérez-Pertejo Y; Reguera RM
Mol Biochem Parasitol; 2012 Feb; 181(2):85-93. PubMed ID: 22033378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]